Download references

This article is part of the supplement: Lupus 2012: New targets, new approaches

Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?

A Thanou, M Munroe, S Kamp, F Carthen, JA James and JT Merrill*

  • * Corresponding author: JT Merrill

Arthritis Research & Therapy 2012, 14(Suppl 3):A47 doi:10.1186/ar3981

Include


Format